GLUE EPS Estimates
Monte Rosa Therapeutics, Inc.
$10.18
+$0.34(+3.46%)
42
Overall
60
Value
36
Tech
31
Quality
Market Cap
$839.48M
Volume
138.56K
52W Range
$8.94 - $25.77
Target Price
$28.00
GLUE EPS estimates: the consensus estimate for Monte Rosa Therapeutics, Inc.'s current fiscal year is -$1.23 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
GLUE EPS Estimates
- EPS estimate, current quarter
- $-0.10
- EPS estimate, next quarter
- $-0.25
- EPS estimate, current year
- $-1.23
- EPS estimate, next year
- $-1.56
- EPS growth, 3-year
- +41.52%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.46 |
| 2024 | $-0.98 |
| 2023 | $-2.63 |
| 2022 | $-2.30 |
| 2021 | $-2.96 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GLUE | $10.18 | +3.5% | 138.56K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Monte Rosa Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW